Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.

MLA

Dioh, W., et al. “Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA Study): A Structured Summary of a Study Protocol for a Randomised Controlled Trial.” Trials, vol. 22, no. 1, Jan. 2021, pp. 1–5. EBSCOhost, https://doi.org/10.1186/s13063-020-04998-5.

APA

Dioh, W., Chabane, M., Tourette, C., Azbekyan, A., Morelot-Panzini, C., Hajjar, L. A., Lins, M., Nair, G. B., Whitehouse, T., Mariani, J., Latil, M., Camelo, S., Lafont, R., Dilda, P. J., Veillet, S., & Agus, S. (2021). Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Trials, 22(1), 1–5. https://doi.org/10.1186/s13063-020-04998-5

Chicago

Dioh, W., M. Chabane, C. Tourette, A. Azbekyan, C. Morelot-Panzini, L. A. Hajjar, M. Lins, et al. 2021. “Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA Study): A Structured Summary of a Study Protocol for a Randomised Controlled Trial.” Trials 22 (1): 1–5. doi:10.1186/s13063-020-04998-5.